Adaptin Bio (APTN) EBT (2023 - 2026)

Adaptin Bio's EBT history runs 4 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

• In Q1 2026, EBT fell 90.04% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$5.7 million (down 69.6% YoY), while the FY2025 annual figure was -$5.2 million, down 66.53% from the prior year.
• EBT came in at -$1.1 million for Q1 2026 at Adaptin Bio, up from -$1.4 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$34155.0 in Q4 2023 to a low of -$1.7 million in Q3 2025.
• A 4-year average of -$867795.1 and a median of -$856836.0 in 2024 frame the typical range for EBT.
• Across the five-year window, EBT tumbled 2479.42% in 2024 and slumped 51.29% in 2025, its largest moves.
• Adaptin Bio's EBT stood at -$34155.0 in 2023, then sank by 2408.67% to -$856836.0 in 2024, then tumbled by 63.44% to -$1.4 million in 2025, then grew by 18.16% to -$1.1 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$1.1 million, -$1.4 million, and -$1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison